title: Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders.
abstract: BACKGROUND
  Chronic cigarette smoking is associated with increased risk for Alzheimer's disease (AD). The goal of this study was to determine if smoking history moderated the associations of age and APOE genotype (the most robust risk factors for AD) on brain amyloid deposition, glucose metabolism, and neurocognition in cognitively-normal elders.
  
  
  METHODS
  Participants (n = 264) were grouped according to their APOE ε4 carrier status (ε4 carrier: APOE4+; non-ε4 carrier: APOE4-) and smoking status (smokers: at least 1 year of smoking during lifetime; never-smokers: no history of smoking). Approximately 89% of the smoking sample was former-smokers. We specifically tested for interactions of smoking status with APOE ε4 carrier status and age on measures of cortical amyloid deposition, glucose metabolism, and neurocognition.
  
  
  RESULTS
  (1) smoking status interacted with APOE ε4 carrier status, where smoker APOE4+ showed lower glucose metabolism and poorer auditory-verbal learning and memory than never-smoking APOE4-, never-smoking APOE4+, and smoking APOE4-; (2) smoking status interacted with age on measures of semantic fluency, processing speed/set-shifting and global neurocognition; smokers, irrespective of APOE ε4 carrier status, demonstrated poorer performance with increasing age than never-smokers; and (3) smoking APOE4+ and never-smoking APOE4+ showed greater cortical amyloid deposition than never-smoking APOE4- and smoking APOE4-.
  
  
  CONCLUSIONS
  The findings indicate consideration of smoking history is essential to both better understand the factors associated with neurobiological and neurocognitive abnormalities in elders, and the risk for development of AD-related neuropathology.
authors.affiliation: Center for Imaging of Neurodegenerative Diseases, San Francisco VA Medical Center, San Francisco, CA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; timothy.durazzo@ucsf.edu.
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Durazzo
authors.affiliation: Center for Imaging of Neurodegenerative Diseases, San Francisco VA Medical Center, San Francisco, CA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden;
authors.forename: Niklas
authors.initials: N
authors.lastname: Mattsson
authors.affiliation: Center for Imaging of Neurodegenerative Diseases, San Francisco VA Medical Center, San Francisco, CA; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA; Departments of Psychiatry, Medicine, and Neurology, University of California, San Francisco, CA.
authors.forename: Michael W
authors.initials: MW
authors.lastname: Weiner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000235:genetics* / Q000378:metabolism / Q000523:psychology; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000523:psychology; D053327:Apolipoprotein E4 / Q000235:genetics*; D001921:Brain / Q000378:metabolism; D003071:Cognition / Q000502:physiology*; D005260:Female; D005838:Genotype; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D058225:Plaque, Amyloid / Q000235:genetics* / Q000378:metabolism / Q000523:psychology; D012307:Risk Factors; D012907:Smoking / Q000235:genetics* / Q000378:metabolism / Q000523:psychology
chemical_list: D053327:Apolipoprotein E4; D005947:Glucose
references.citation: Ann Neurol. 2011 Jan;69(1):181-92
references.pmid: 21280088
references.citation: Drug Alcohol Depend. 2012 Apr 1;122(1-2):105-11
references.pmid: 21992872
references.citation: Psychol Rev. 1996 Jul;103(3):403-28
references.pmid: 8759042
references.citation: Brain. 2011 Jul;134(Pt 7):2013-24
references.pmid: 21690575
references.citation: Addict Biol. 2014 Jan;19(1):132-43
references.pmid: 22943795
references.citation: Lancet Neurol. 2012 Nov;11(11):1006-12
references.pmid: 23079557
references.citation: Arch Neurol. 2011 Jan;68(1):58-66
references.pmid: 21220675
references.citation: Arch Neurol. 2012 Feb;69(2):215-22
references.pmid: 22332188
references.citation: Neuroimage. 1999 Feb;9(2):195-207
references.pmid: 9931269
references.citation: Brain. 2009 May;132(Pt 5):1310-23
references.pmid: 19042931
references.citation: Front Aging Neurosci. 2013 Apr 01;5:11
references.pmid: 23554593
references.citation: Biol Psychiatry. 2001 Feb 1;49(3):194-9
references.pmid: 11230870
references.citation: J Cell Mol Med. 2008 Dec;12(6B):2762-71
references.pmid: 18318693
references.citation: Alzheimer Dis Assoc Disord. 2012 Oct-Dec;26(4):300-6
references.pmid: 22185783
references.citation: Exp Gerontol. 2007 Jan-Feb;42(1-2):129-38
references.pmid: 16839732
references.citation: Neurobiol Aging. 2014 Apr;35(4):819-26
references.pmid: 24199961
references.citation: J Neurosci. 2014 Jun 18;34(25):8612-7
references.pmid: 24948815
references.citation: J Neurosci. 2012 Dec 12;32(50):18227-33
references.pmid: 23238736
references.citation: J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9
references.pmid: 22002422
references.citation: Ann Neurol. 2010 Jan;67(1):122-31
references.pmid: 20186853
references.citation: Arch Neurol. 2009 Dec;66(12):1447-55
references.pmid: 20008648
references.citation: Dtsch Arztebl Int. 2011 Nov;108(44):743-50
references.pmid: 22163250
references.citation: Neurology. 2009 Oct 13;73(15):1193-9
references.pmid: 19822868
references.citation: Neurology. 2013 Nov 12;81(20):1732-40
references.pmid: 24132377
references.citation: Neurobiol Aging. 2011 Jul;32(7):1207-18
references.pmid: 19660834
references.citation: Arch Neurol. 2010 Apr;67(4):462-8
references.pmid: 20385913
references.citation: Lancet Neurol. 2011 Sep;10(9):819-28
references.pmid: 21775213
references.citation: Neurology. 2006 Jun 27;66(12):1837-44
references.pmid: 16801647
references.citation: Ann Neurol. 2012 Oct;72 (4):578-86
references.pmid: 23109153
references.citation: Neurobiol Aging. 2004 May-Jun;25(5):641-50
references.pmid: 15172743
references.citation: Int J Environ Res Public Health. 2010 Oct;7(10 ):3760-91
references.pmid: 21139859
references.citation: Drug Alcohol Depend. 2013 Dec 1;133(2):704-11
references.pmid: 24051060
references.citation: Biol Psychol. 2000 Oct;54(1-3):35-54
references.pmid: 11035219
references.citation: Ann Neurol. 1999 Mar;45(3):358-68
references.pmid: 10072051
references.citation: J Alzheimers Dis. 2011;26 Suppl 3:159-99
references.pmid: 21971460
references.citation: Ann Neurol. 2010 Mar;67(3):308-16
references.pmid: 20373342
references.citation: Alzheimers Dement. 2012;8(2):131-68
references.pmid: 22404854
references.citation: Neurobiol Aging. 2014 Mar;35(3):576-84
references.pmid: 24269021
references.citation: Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45
references.pmid: 24924665
references.citation: N Engl J Med. 2013 Jan 24;368(4):341-50
references.pmid: 23343063
references.citation: Arch Neurol. 2011 Sep;68(9):1185-90
references.pmid: 21555601
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5
references.pmid: 10984517
references.citation: Ann Neurol. 2010 Jan;67(1):114-21
references.pmid: 20186856
references.citation: Neuroimage. 1999 Feb;9(2):179-94
references.pmid: 9931268
references.citation: Arch Neurol. 2010 Dec;67(12):1473-84
references.pmid: 20697030
references.citation: Alzheimers Dement. 2011 May;7(3):280-92
references.pmid: 21514248
references.citation: Lancet Neurol. 2013 Feb;12(2):207-16
references.pmid: 23332364
references.citation: JAMA Neurol. 2013 Mar 1;70(3):299-300
references.pmid: 23599927
references.citation: Cereb Cortex. 2004 Jan;14(1):11-22
references.pmid: 14654453